Belluscura Shares Surge on Strong Sales and Improved Outlook

August 27, 2024 08:07 AM PDT | By Team Kalkine Media
 Belluscura Shares Surge on Strong Sales and Improved Outlook
Image source: shutterstock

Belluscura (LSE:BELL), known for its development of lightweight and portable oxygen enrichment technology, reported significant sales growth and an optimistic trading outlook on Tuesday as it geared up for the full commercial launch of its new DISCOV-R portable oxygen concentrator.

At its annual general meeting, the AIM-listed company highlighted a notable surge in sales and a positive forecast for the remainder of 2024. July saw record sales of $0.71 million, surpassing the previous peak of $0.52 million achieved in June.

The company anticipates that the robust sales trend will persist, driven by increasing market acceptance of its X-PLOR device and the anticipated success of the DISCOV-R. This device, introduced to the US market through a soft launch in June, has been well-received.

The DISCOV-R, weighing just over six pounds, offers 50% more oxygen output compared to the leading competitor and delivers more oxygen per weight than any other portable device available. The high demand for the DISCOV-R is evident, with all units produced in June and July already sold.

The full commercial launch of the DISCOV-R is scheduled for mid-fourth quarter, which has led Belluscura to update its trading outlook for the final months of 2024. The company now projects full-year revenue for 2024 to be between $8 million and $10 million, a significant increase from the $0.83 million reported in 2023.

Additionally, Belluscura anticipates achieving positive EBITDA in the first quarter of the 2025 financial year, with an annualized revenue run rate of $14 million to $16 million by year-end.

To support its ongoing expansion and meet the high demand for the DISCOV-R, Belluscura is exploring various financing options, including debt and credit facilities. The increased sales of X-PLOR units have reduced raw materials inventory, highlighting the need for additional funding to sustain the growth of the DISCOV-R.

As of 1216 BST, shares in Belluscura rose by 43.86% to 15.82p.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.


Sponsored Articles


Investing Ideas

Previous Next